Moderna reported its latest quarterly results before the bell today, coming in mixed. The majority of its sales for the quarter were from its COVID-19 vaccine, while it also revealed plans to apply for full U.S. authorization of the vaccine by the end of the month. Wake Up With Cheddar breaks down some of the key highlights from Moderna's report.